Cambium Biomaterials Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 205

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $101M

  • Investors
  • 24

Cambium Biomaterials General Information

Description

Developer of an advanced materials platform designed to accelerate the discovery, development, and scale of next-generation high-performance materials. The company offers an AI-driven materials platform integrated with chemistry, materials science, biology, and composite manufacturing, enabling aerospace, automotive, and other high-performance manufacturing sectors to move efficiently from material discovery to certified, high-volume production.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 111 Maryland Street
  • El Segundo, CA 90245
  • United States
+1 (415)
Primary Industry
Aerospace and Defense
Other Industries
Other Materials
Corporate Office
  • 111 Maryland Street
  • El Segundo, CA 90245
  • United States
+1 (415)

Cambium Biomaterials Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambium Biomaterials Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 05-Jan-2026 $101M Completed Generating Revenue
4. Later Stage VC (Series A1) 14-Aug-2025 Completed Generating Revenue
3. Early Stage VC (Series A) 08-Nov-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 02-Sep-2021 $8.01M $11M Completed Startup
1. Seed Round $3M $3M Completed Startup
To view Cambium Biomaterials’s complete valuation and funding history, request access »

Cambium Biomaterials Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A-3
Series A-2
Series A-1
Series A 30,417,553 $0.000010 $0.2 $0.2 1x $0.2 3.97%
Seed 36,452,005 $0.000010 $0.08 $0.08 1x $0.08 4.75%
To view Cambium Biomaterials’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cambium Biomaterials Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an advanced materials platform designed to accelerate the discovery, development, and scale of next-generat
Aerospace and Defense
El Segundo, CA
205 As of 2026

Stamford, CT
 

Kernersville, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cambium Biomaterials Competitors (7)

One of Cambium Biomaterials’s 7 competitors is Hexcel, a Corporation company based in Stamford, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hexcel Corporation Stamford, CT
Tex Tech Industries Formerly PE-Backed Kernersville, NC
Karman Holdings Formerly PE-Backed Huntington Beach, CA
Park Aerospace Corporation New York, NY
Toray Industries Corporation Tokyo, Japan
You’re viewing 5 of 7 competitors. Get the full list »

Cambium Biomaterials Patents

Cambium Biomaterials Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026236462-A1 Phthalonitrile and polyimide-based compositions Pending 07-May-2025
US-20260242618-A1 Polymer foam comprising phthalonitrile-based resins and carboxylate-containing blowing agents and methods of preparing same Pending 14-Feb-2025
WO-2026174264-A1 Polymer foam comprising phthalonitrile-based resins and carboxylate-containing blowing agents and methods of preparing same Pending 14-Feb-2025
WO-2026174266-A1 Polymer foam comprising phthalonitrile-based resins and carboxylate-containing blowing agents and methods of preparing same Pending 14-Feb-2025
WO-2025179261-A1 Phthalonitrile-based precursors, high-temperature resin, and composite compositions thereof Pending 23-Feb-2024 C08G65/38
To view Cambium Biomaterials’s complete patent history, request access »

Cambium Biomaterials Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cambium Biomaterials Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alumni Ventures Venture Capital Minority
Inevitable Ventures Venture Capital Minority
J17 Ventures PE/Buyout Minority
JACS Capital Partners Venture Capital Minority
Mañana Investments Venture Capital Minority
You’re viewing 5 of 24 investors. Get the full list »

Cambium Biomaterials Acquisitions (1)

Cambium Biomaterials’s most recent deal was a Merger/Acquisition with SHD Composites. The deal was made on 02-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SHD Composites 02-Dec-2025 Merger/Acquisition Industrial Supplies and Parts
To view Cambium Biomaterials’s complete acquisitions history, request access »

Cambium Biomaterials Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
SHD Composites Sleaford, United Kingdom 2010

Cambium Biomaterials FAQs

  • When was Cambium Biomaterials founded?

    Cambium Biomaterials was founded in 2019.

  • Where is Cambium Biomaterials headquartered?

    Cambium Biomaterials is headquartered in El Segundo, CA.

  • What is the size of Cambium Biomaterials?

    Cambium Biomaterials has 205 total employees.

  • What industry is Cambium Biomaterials in?

    Cambium Biomaterials’s primary industry is Aerospace and Defense.

  • Is Cambium Biomaterials a private or public company?

    Cambium Biomaterials is a Private company.

  • What is the current valuation of Cambium Biomaterials?

    The current valuation of Cambium Biomaterials is .

  • What is Cambium Biomaterials’s current revenue?

    The current revenue for Cambium Biomaterials is .

  • How much funding has Cambium Biomaterials raised over time?

    Cambium Biomaterials has raised $142M.

  • Who are Cambium Biomaterials’s investors?

    Alumni Ventures, Inevitable Ventures, J17 Ventures, JACS Capital Partners, and Mañana Investments are 5 of 24 investors who have invested in Cambium Biomaterials.

  • Who are Cambium Biomaterials’s competitors?

    Hexcel, Tex Tech Industries, Karman Holdings, Park Aerospace, and Toray Industries are some of the 7 competitors of Cambium Biomaterials.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process